-
Mashup Score: 2Current and Future Treatments of Vascular Cognitive Impairment - 2 month(s) ago
Correspondence to: Vincent Chung Tong Mok, MD, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32, Ngan Shing St, New Territories, Hong Kong SAR, China. Email For Sources of Funding and Disclosures, see page 832. Correspondence to: Vincent Chung Tong Mok, MD, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32, Ngan Shing St, New Territories, Hong
Source: www.ahajournals.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 1
Radiotherapy is one of the mainstay treatment modalities for the management of non-metastatic head and neck cancer (HNC). Notable improvements in trea…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2GIST Updates from CTOS 2023 - 3 month(s) ago
Dr. Herbert Loong of the Chinese University of Hong Kong to presented “GIST Updates from CTOS 2023” to GIST patients and caregivers on November 27th at 5pm E…
Source: www.youtube.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2EMA and EORTC soft tissue and bone sarcoma workshop - 4 month(s) agoSource: www.youtube.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0
July St. Jude-VIVA Survivorship Series 3: Medulloblastoma Friday, 16 February 2024 8:00PM – 9:30PM (UTC+8 Singapore Time) | 7:00AM – 8:30AM (UTC-5 Memphis Time) Check your Time Zone VIVA Foundation for Children with Cancer in collaboration with the St. Jude Children’s Research Hospital is excited to bring a third series of the St Jude-VIVA Survivorship! This series will feature case presentations followed by discussion of the data informing current clinical practice recommendations and guidelines, as
Source: mailchi.mpCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5LIBRETTO-431: Selpercatinib in RET Fusion–Positive NSCLC - 5 month(s) ago
A medical oncologist discusses data from the LIBRETTO-431 clinical trial looking at first-line selpercatinib vs chemotherapy and pembrolizumab in RET fusion–positive NSCLC.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 19Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer - 5 month(s) ago
NTRK fusions result in constitutively active oncogenic TRK proteins responsible for ∼ 0.2 % of non-small cell lung cancer (NSCLC) cases. Approximately…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 0Health Promo - 6 month(s) ago
Moderator: Prof Wong Chi-sang, Martin (Centre Director, Centre for Health Education and Health Promotion, CUHK) Target Participants: Medical doctors, nurses , community health practitioners, health service providers, academics, and postgraduate and undergraduate students Organiser: Centre for Health Education and Health Promotion, CUHK This series of webinars on infectious disease prevention is supported by the following organisations: The Jockey Club School of Public Health and Primary Care, Hong Kong
Source: www.chep.cuhk.edu.hkCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5GIST Updates from CTOS 2023 - 6 month(s) ago
Dr. Herbert Loong of the Chinese University of Hong Kong to presented “GIST Updates from CTOS 2023” to GIST patients and caregivers on November 27th at 5pm E…
Source: www.youtube.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 2
This report highlights the need for improvements in the early detection of lung cancer and showcases early detection approaches and tools.
Source: www.lungcancerpolicynetwork.comCategories: General Medicine News, Oncologists2Tweet
RT @IpBonaventure: Current and Future Treatments of Vascular Cognitive Impairment | Stroke https://t.co/cioDXcHY9v A review on treatments o…